Skip to content
Review Open access

Nrf2/HO-1 signaling in retinal neurodegenerative diseases: redox homeostasis, cytoprotection, and therapeutic perspectives

Sep 2026 · Frontiers in Medicine · 0 citations · 103 references

TL;DR

This review critically synthesizes the cytoprotective roles, evidence boundaries, translational challenges, and future directions of Nrf2/HO-1 signaling in RNDs, organized around retinal cell types, redox homeostasis-related injury mechanisms, disease-specific evidence, and intervention strategies.

Abstract

Retinal neurodegenerative diseases (RNDs) represent a major group of disorders leading to irreversible visual impairment. Persistent oxidative stress, mitochondrial dysfunction, inflammatory responses, lipid peroxidation, and disruption of neurovascular unit homeostasis are closely implicated in retinal neuronal and vascular injury. Nuclear factor erythroid 2–related factor 2 (Nrf2) and its downstream effector heme oxygenase-1 (HO-1) constitute a key regulator y axis in cellular antioxidant defense and adaptive stress responses. Current preclinical evidence suggests that Nrf2/HO-1 signaling may participate in retinal cytoprotection, inflammatory regulation, and maintenance of neurovascular homeostasis in RNDs by modulating redox homeostasis and interconnected injury responses. This review critically synthesizes the cytoprotective roles, evidence boundaries, translational challenges, and future directions of Nrf2/HO-1 signaling in RNDs, organized around retinal cell types, redox homeostasis-related injury mechanisms, disease-specific evidence, and intervention strategies. Further translation will require stronger causal validation, improved ocular delivery, and better cell type-specific targeting.

Read PDF

Similar papers

Review Aug 2026

KEAP1-Nrf2 Signaling in Chronic Inflammatory Disorders: Integrating Redox Biology, Quantitative Evidence, and Precision Therapeutics.

KEAP1-Nrf2 represents a context-dependent therapeutic axis with substantial potential across chronic inflammatory diseases and integrating quantitative evidence, precision delivery, biomarker-guided approaches, and computational strategies may facilitate clinical translation while addressing risks associated with susta...

Abdul Shadab · 0 citations
Review Aug 2026

From Food to Function: Nutraceutical-Based Modulation of Mitochondrial, Inflammatory, and Epigenetic Networks in Retinal Neurodegeneration.

Retinal neurodegenerative diseases, such as age-related macular degeneration, diabetic retinopathy, glaucoma, and inherited retinal dystrophies, are major causes of irreversible vision loss worldwide. Although they originate from different causes, these disorders increasingly appear to share a network of cellular stres...

Harshith J Manjunatha, Gowthami Mahalingappa, Suraj R Varadaraju et al. · 0 citations
Review Sep 2026

The redox paradox in neurological disorders: balancing cytoprotection, ferroptosis, and therapeutic targeting.

Neurological disorders, including ischaemic and haemorrhagic stroke, traumatic brain injury, and chronic neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, represent a major global health burden. Despite diverse etiologies, these conditions share common pathological mec...

Tanvi Premchandani, M. Qutub, Tejaswini Thave et al. · 0 citations
Review Open access Sep 2026

The HIF-1α–Mitochondria Axis in Alzheimer's Disease: Therapeutic Potential of Roxadustat in Restoring Neuronal Bioenergetics and Cognitive Function

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by amyloid-β (Aβ) plaques, tau pathology, mitochondrial dysfunction, oxidative stress, neuroinflammation, and cerebral hypoperfusion. Emerging evidence suggests that dysregulation of the hypoxia-inducible factor-1 alpha (HIF-1α)-mitochon...

R. Elavarasi, P. A, V. R et al. · 0 citations
Review Open access Sep 2026

Ferroptosis in retinal neurodegeneration: mechanistic vulnerability, therapeutic targeting, and translational barriers

Current evidence supporting ferroptosis-related vulnerability in retinal neurodegenerative diseases is synthesized and emerging enabling strategies are evaluated, including nanocarrier-based delivery, long-acting gene modulation, and biomarker frameworks integrating ocular fluids, imaging, multi-omics, and artificial i...

Guang-Guang Wu, Su-Yu Wang, Zi-Yi Chen et al. · 0 citations
Review Open access Aug 2026

Redox-exercise crosstalk in neurodegenerative diseases: mechanistic perspectives on antioxidant interactions with Nrf2-BDNF signaling, autophagy, and mitochondrial plasticity

Neurodegenerative diseases (NDDs), including Alzheimer’s disease and Parkinson’s disease, are characterized by progressive neuronal loss driven by oxidative stress, mitochondrial dysfunction, and impaired cellular homeostasis. Emerging research highlights a complex interplay between physical exercise and antioxidant me...

Li-Fu Liu, Yunpeng Zhao · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.